Slide 1: Q1 2024 Financial Results
Q1 2024 Financial Results May 14, 2024 1 © 2024 Forian Inc. All Rights Reserved.
Slide 2: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In
Slide 3: Revenue and Adjusted EBITDA
Revenue and Adjusted EBITDA ($000's) Three Months Ended March 31, Period-over- 2024 2023 Period % Unaudited Unaudited Change Revenue $ 4,877 $ 4,870 0% Loss from continuing operations, net of tax $ (1,213) $ (2,249) 46% Income from discontinued operations, net of tax $ - $ 8,747 100% Net (loss) inco
Slide 4: Healthcare Information Revenue Trend
Healthcare Information Revenue Trend Q1 2024 revenue consistent with prior year after expected customer attrition 4 © 2024 Forian Inc. All Rights Reserved.
Slide 5: Costs and Expenses
Costs and Expenses Focused business model drives cost reductions in other costs and expenses while continuing to invest in information platform: • 6% reduction in Q1 vs same QTR last Year Note: Other costs and expenses excludes litigation costs, separation expenses, stock compensation and depreciati
Slide 6: Adjusted EBITDA – continuing operations
Adjusted EBITDA – continuing operations Continued improvement in Adjusted EBITDA driven by revenue growth and cost management Adjusted EBITDA is a non-U.S. GAAP measure. See Appendix for further information, including a reconciliation of Adjusted EBITDA to Net Loss. 6 © 2024 Forian Inc. All Rights R
Slide 7: Summary Balance Sheet Data $000's
Summary Balance Sheet Data $000’s March 31, December 31, 2024 2023 Cash and equivalents $47,435 $48,340 Net working capital $49,563 $50,439 Convertible note and accrued interest (due 9/2025) $23,982 $24,870 Shares outstanding 31,093 30,920 7 © 2024 Forian Inc. All Rights Reserved.
Slide 8: Full Year 2024 Outlook
Full Year 2024 Outlook Expect 2024 Healthcare Information Revenue growth of 5-15% Expect Adjusted EBITDA as a percentage of revenues (“EBITDA Margin”) of 8% to 12% in 2024 while continuing to expand information assets The outlook provided above constitutes forward-looking information within the mean
Slide 9: Q&A
Q&A 9 © 2024 Forian Inc. All Rights Reserved.
Slide 10: Slide 10
Slide 11: Appendix
Appendix 11 © 2024 Forian Inc. All Rights Reserved.
Slide 12: Reconciliation of U.S. GAAP to Non-GAAP Financial Measures
Reconciliation of U.S. GAAP to Non-GAAP Financial Measures This presentation includes a non-GAAP measure, which we define as financial information that has not been prepared in accordance with U.S. GAAP. The non-U.S. GAAP financial measure provided herein is earnings before interest, taxes, non-cash
Slide 13: Non-U.S. GAAP Reconciliations Reported Net Income to Adjusted EBITDA
Non-U.S. GAAP Reconciliations Reported Net Income to Adjusted EBITDA For the Three Months Ended March 31, 2024 2023 Revenue $ 4,877,378 $ 4,870,387 Net loss from continuing operations $ (1,212,615) $ (2,248,799) Depreciation and amortization 8,887 38,430 Stock based compensation expense 1,658,915 1,
Slide 14: Adjusted EBITDA Margin
Adjusted EBITDA Margin Improved EBITDA Margins reflect scalability of business Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by revenues 14 © 2024 Forian Inc. All Rights Reserved.
Slide 15: © 2024 Forian Inc. All Rights Reserved.
© 2024 Forian Inc. All Rights Reserved.